ARGS
Argos Therapeutics, Inc.
ARGS
ARGS
Delisted
ARGS was delisted on the 24th of April, 2018.
25 hedge funds and large institutions have $9.3M invested in Argos Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$144K | |
| 2 | +$134K | |
| 3 | +$82K | |
| 4 |
SIM
Spark Investment Management
New York
|
+$79K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$41.3K |
Top Sellers
| 1 | -$3.49M | |
| 2 | -$154K | |
| 3 | -$52K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$23K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$13K |